Business Standard

Friday, December 27, 2024 | 05:04 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Remus Pharmaceuticals Share Price

Know More
BSENSE
Stock not traded

2,452.35 93.15 (3.95%)

03:40 PM, 26-Dec-2024

BSE : 78788

NSE : REMUS

Sector : Health care

ISIN Code : INE0O5T01011

  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Market Cap (₹ Cr)

1,444

Traded Value (₹ Cr)

1.54

Volume (Shares)

6,300

Face Value (₹)

10

52-Week High (₹)

2,834.75

52-Week High Date

03-Sep-2024

52-Week Low (₹)

1,200.00

52-Week Low Date

13-Mar-2024

All Time High (₹)

2,834.75

All Time High Date

03-Sep-2024

All Time Low (₹)

427.81

All Time Low Date

29-May-2023

Remus Pharmaceuticals Ltd

Remus Pharmaceuticals Limited was originally incorporated as `Remus Pharmaceuticals Private Limited' as a Private Limited Company vide Certificate of Incorporation dated September 21 2015 issued by the Assistant Registrar of Companies Gujarat. Subsequently Company converted from a Private to Public and the name of the Company was changed to Remus Pharmaceuticals Limited on January 06 2023 by the Registrar of Companies Ahmedabad.The Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs. It deals in API (Active Pharmaceutical Ingredient) provide technical consultancy services to various distributors for preparation of reports on the dossiers of the pro...
Read More

Remus Pharmaceuticals Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

1,444

EPS - TTM (₹) [C]

34.52

P/E Ratio (X) [C]

71.04

Face Value (₹) 10
Latest Dividend (%)10.00
Latest Dividend Date 19-Nov-2024
Dividend Yield (%) 0.04
Book Value Share (₹) [C]147.41
P/B Ratio (₹) [C]16.64

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)

2,330.00

2,540.00

Year Low/High (₹)

1,200.00

2,835.00

All time Low/High (₹)

0.00

2,835.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week%%-0.94-0.84%
1 Month%%-1.91-1.84%
3 Month%%-8.58-9.41%
6 Month%%-0.26-0.50%
1 Year%%10.0010.77%
3 Year%%37.3739.68%

Company Info

Company Information

Registered Office: 1101 to 1103 South Tower One42, B/H Ashok Vatika Amblibopal Rd,Ahmedabad,Gujarat-380054 Ph: 91-079-29999857

Email:cs@remuspharma.com

URL:https://www.remuspharma.com

FAQs about Remus Pharmaceuticals Ltd

1. What's the Remus Pharmaceuticals Ltd share price today?
Remus Pharmaceuticals Ltd share price was Rs 2,452.35 at 03:40 PM IST on 26th Dec 2024. Remus Pharmaceuticals Ltd share price was up by 3.95% over the previous closing price of Rs 2,359.20. Remus Pharmaceuticals Ltd share price trend:

  • Last 1 Month: Remus Pharmaceuticals Ltd share price moved up by % on _
  • Last 3 Months: Remus Pharmaceuticals Ltd share price moved up by % on _
  • Last 12 Months: Remus Pharmaceuticals Ltd share price moved up by % on _
  • Last 3 Years: Remus Pharmaceuticals Ltd price moved up by % on _


2. How can I quickly analyse the performance of the Remus Pharmaceuticals Ltd stock?
The performance of the Remus Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 71.04
  • Price to book value ratio is 16.64
  • Dividend yield of 0.04
  • The EPS (trailing 12 months) of the Remus Pharmaceuticals Ltd stock is Rs 34.52


3. What is the market cap of Remus Pharmaceuticals Ltd?
Remus Pharmaceuticals Ltd has a market capitalisation of Rs 1,444 crore.


4. What is Remus Pharmaceuticals Ltd's 52-week high/low share price?
The Remus Pharmaceuticals Ltd’s 52-week high share price is Rs 0.00 and 52-week low share price is Rs 0.00.


5. Is the Remus Pharmaceuticals Ltd profitable?
On a consolidated basis, Remus Pharmaceuticals Ltd reported a loss of Rs crore on a total income of Rs crore for the quarter ended . For the year ended , Remus Pharmaceuticals Ltd had posted a loss of Rs crore on a total income of Rs crore.


6. Which are Remus Pharmaceuticals Ltd’s peers in the Health care sector?
Remus Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Cian Healthcare, Venmax Drugs, Brawn Biotech.


7. Who owns how much in Remus Pharmaceuticals Ltd?
Key changes to the Remus Pharmaceuticals Ltd shareholding are as follows:

  • Promoter holding in Remus Pharmaceuticals Ltd has gone up to 70.84 per cent as of Sep 2024 from 69.61 per cent as of Sep 2023.